Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

100880

registered interest
date	24/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Public Health: Business
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the emphasis placed on tackling and preventing lifestyle-related diseases in the NHS Five Year Forward View, published in October 2014, whether he has any plans to review and reform the voluntary responsibility deal.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	211871
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The emphasis placed on tackling and preventing lifestyle-related diseases in the NHS Five Year Forward View underlines the importance of the Public Health Responsibility Deal and the part it plays in supporting people to make healthier choices and tackle the behaviours which lead to chronic health conditions. Over 700 community, voluntary, public sector (National Health Service as well as national and local Government), public health and commercial organisations have signed up to play their part in improving public health.</p><p> </p><p> </p><p> </p><p>The Deal is already focussed on tackling many of the key causes of lifestyle-related ill health outlined in the NHS Five Year Forward View, including obesity, smoking and harmful drinking. The Deal’s pledges tackle a wide range of issues, including: healthier diets (e.g. reformulation for reduced salt levels, elimination of trans-fats and calorie reduction); fostering a culture of responsible drinking (e.g. lower alcohol by volume products, alcohol labelling, increasing awareness of alcohol units); increasing physical activity levels (e.g. physical activity in the workplace and active travel) and improving the health of their staff (e.g. accreditation of occupational health services, supporting employees with mental health conditions in the workplace, smoking cessation and healthier staff restaurants). The Deal will continue to play an important part in delivering these ambitions.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:09:23 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

100881

registered interest
date	24/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ebola
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to his contribution of 13 October 2014, Official Report, column 30, on bed capacity for dealing with potential Ebola patients, how many additional beds will be made available; and at which hospitals they will be made available.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	211872
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The National Health Service has two ‘Trexler’ beds on stand-by 24 hours a day at the Royal Free Hospital in London, available for use within six hours maximum to allow staff to be mobilised. If needed further beds at the Royal Free Hospital, Newcastle Royal Victoria Infirmary, Royal Liverpool and Broadgreen University Hospital and Sheffield Teaching Hospital would be made available, totalling 12 beds.</p><p> </p><p> </p><p> </p><p>The Department believes this will be sufficient even in the event of an increase in the numbers of cases of Ebola in this country. If there is a significant upscale in numbers further beds could be made available. This would amount to at least 26 beds referenced in the Secretary of State for Health’s statement on 13 October, <em>Official Report, </em>Column 30.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:30:23 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

100882

registered interest
date	24/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cervical Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his policy is on the retention of cervical cancer indicators in the Quality and Outcomes Framework.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	211899
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>National Institute for Health and Care Excellence’s independent advisory committee recommends new indicators or changes to existing indicators. NHS Employers, on behalf of NHS England, then negotiate with the General Practitioners Committee of the British Medical Association on which of the published indicators should be applied nationally and what the financial value and payment thresholds for those indicators should be.</p><p> </p><p> </p><p> </p><p>There are currently four indicators within the Quality and Outcomes Framework (QOF) that relate to cervical screening. These have had a positive impact upon increasing the participation in the screening programme in the past years. In April this year, one indicator on cervical screening: <em>The contractor ensures there is a system for informing all women of the results of cervical screening tests</em> was retired, as part of efforts to reduce QOF by more than a third to free up space for GPs to provide more personalised care. Indicators were retired where they were duplicating other existing incentives, were of low clinical value, were unnecessarily prescriptive or were already embedded in clinical practice. The removal of the indicators will reduce bureaucracy, unnecessary patient testing and unnecessary frequency of patient recall and recording.</p><p> </p><p> </p><p> </p><p>There are two indicators that are relevant for all cancers. Indicators on Breast and Bowel Cancer are not currently within the QOF; however Public Health England will continue to explore with NICE whether these conditions should be included.</p><p> </p><p> </p><p>For 2015-16, there will not be any alterations to the cervical screening or cancer indicators, nor any new indicators for cancer, including breast and bowel cancer.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 211903 question first answered 29/10/2014 17:20:41 answering member 3918 label Biography information for Jane Ellison
tabling member	1390 label Biography information for Mr John Baron

100883

registered interest
date	24/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospitals: Greater London
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many times the Parliamentary Under-Secretary of State for Public Health has visited (a) Chelsea and Westminster Hospital, (b) Royal Brompton Hospital, (c) King's College Hospital and (d) St Thomas's Hospital in her ministerial capacity.
tabling member constituency	Copeland
tabling member printed	Mr Jamie Reed
uin	211900
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Since September 2012 I have visited:</p><p> </p><p> </p><p> </p><p>23 December 2013, St Thomas’s hospital</p><p> </p><p> </p><p> </p><p>6 March 2014, Kings College hospital</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:28:08 answering member 3918 label Biography information for Jane Ellison
tabling member	1503 label Biography information for Mr Jamie Reed

100889

registered interest
date	24/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his policy is on the inclusion of (a) breast and (b) bowel cancer indicators in the Quality and Outcomes Framework.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	211903
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>National Institute for Health and Care Excellence’s independent advisory committee recommends new indicators or changes to existing indicators. NHS Employers, on behalf of NHS England, then negotiate with the General Practitioners Committee of the British Medical Association on which of the published indicators should be applied nationally and what the financial value and payment thresholds for those indicators should be.</p><p> </p><p> </p><p> </p><p>There are currently four indicators within the Quality and Outcomes Framework (QOF) that relate to cervical screening. These have had a positive impact upon increasing the participation in the screening programme in the past years. In April this year, one indicator on cervical screening: <em>The contractor ensures there is a system for informing all women of the results of cervical screening tests</em> was retired, as part of efforts to reduce QOF by more than a third to free up space for GPs to provide more personalised care. Indicators were retired where they were duplicating other existing incentives, were of low clinical value, were unnecessarily prescriptive or were already embedded in clinical practice. The removal of the indicators will reduce bureaucracy, unnecessary patient testing and unnecessary frequency of patient recall and recording.</p><p> </p><p> </p><p> </p><p>There are two indicators that are relevant for all cancers. Indicators on Breast and Bowel Cancer are not currently within the QOF; however Public Health England will continue to explore with NICE whether these conditions should be included.</p><p> </p><p> </p><p>For 2015-16, there will not be any alterations to the cervical screening or cancer indicators, nor any new indicators for cancer, including breast and bowel cancer.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 211899 question first answered 29/10/2014 17:20:41 answering member 3918 label Biography information for Jane Ellison
tabling member	1390 label Biography information for Mr John Baron

100397

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Answers of 30 March 2011, Official Report, column 399W, to the hon. Member for Colne Valley, and of 28 March 2011, Official Report, House of Lords, column WA217, to Lord Morris of Manchester, whether, when the dependents and widows of those who contracted hepatitis C following treatment with NHS blood products, but who died before 29 August 2003, were given the opportunity to apply for Skipton Fund lump sum payments during a two month period in January to March 2011 the fact that (a) registrations made after the 31 March 2011 deadline could be accepted on a case-by-case basis where there was a valid reason for the applicant to have missed the registration deadline and (b) applicants needed only to register with the fund by the deadline and could compile the necessary medical evidence later were communicated through the channels listed in Deposited Paper DEP2011-0543.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211655
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The decision that claims to the Skipton Fund in respect of people who died before 29 August 2003 could be registered after 31 March 2011 on a case-by-case basis, where there was a valid reason for the applicant to have missed the registration deadline, was communicated by the Skipton Fund on its website. It was not communicated through the other channels listed in Deposited Paper DEP2011-0543.</p><p> </p><p><strong> </strong></p><p> </p><p>The Skipton Fund website still states that it is possible to apply for payments on behalf of the estate of someone who died prior to 29 August 2003, but claimants are asked to contact the Skipton Fund to discuss whether the claimant has a valid reason for missing the original deadline for registering claims of 31 March 2011. <br> <br></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:38:11 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

100400

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS improves the diagnosis and treatment of pancreatic cancer.
tabling member constituency	Birkenhead
tabling member printed	Mr Frank Field
uin	211514
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Achieving earlier diagnosis of cancer is key to our ambition to save an additional 5,000 lives per year by 2014-15. We are investing £450 million to achieve early diagnosis of cancer through better public awareness, better screening and better access to key diagnostic tests. However we know that early diagnosis of pancreatic cancer can be very difficult as the symptoms are shared with a wide range of benign conditions.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) Referral Guidelines for Suspected Cancer (2005) are available to help general practitioners assess when it is appropriate to refer patients for suspected cancer, including pancreatic cancer. NICE is in the process of updating the guidelines to ensure that these reflect latest evidence and can continue to support general practitioners (GPs) to identify patients with suspected cancer symptoms and urgently refer them as appropriate. NICE’s anticipated publication date for the revised guidelines is May 2015.</p><p> </p><p> </p><p> </p><p>We understand that NHS England has asked NICE to develop a clinical guideline and quality standard on pancreatic cancer.</p><p> </p><p> </p><p> </p><p>At a local level, it is for individual clinical commissioning groups to promote and enhance the diagnostic capability to deliver better outcomes. Surgery, radiotherapy and chemotherapy treatments that may be used for pancreatic cancer are commissioned at the moment by NHS England. NHS England’s pancreatic cancer service specification clearly defines what it expects to be in place for providers to offer evidence-based, safe and effective pancreatic cancer services. This service specification has been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe core and developmental service standards.</p><p> </p><p> </p><p> </p><p>NHS England has also committed to make up to £6 million available over the next three years to support six trials by Cancer Research UK into the use of Stereotactic Ablative Radiotherapy (SABR), an innovative radiotherapy treatment. This will allow patients to receive SABR treatment now, where clinicians think they could benefit. At the same time doctors can fully assess the effectiveness of these treatments so that in future, if it proves to be effective, they will be available for all relevant patients on the NHS. One of these six trials will be on pancreatic cancer.</p><p> </p><p><strong> </strong></p><p> </p><p>The Department published Improving Outcomes for Upper Gastro-Intestinal Cancers in 2001, which describes best practice in the delivery of services for patients with all types of upper gastro-intestinal cancer, including pancreatic cancer.<br> <br> NICE has recommended gemcitabine as a treatment option for pancreatic cancer in technology appraisal guidance published in May 2001, subject to certain clinical criteria and is currently appraising a number of other pancreatic cancer drugs. Patients have the right to drugs and treatments that have been recommended by NICE technology appraisal guidance for use in the National Health Service, where their doctor believes they are clinically appropriate. <br> <br> A number of drugs to treat pancreatic cancers are also available through the Cancer Drugs Fund.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 16:58:52 answering member 3918 label Biography information for Jane Ellison
tabling member	478 label Biography information for Lord Field of Birkenhead

100404

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Pendle
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many (a) men and (b) women in Pendle constituency were classified as (i) overweight and (ii) obese in each of the last 10 years.
tabling member constituency	Pendle
tabling member printed	Andrew Stephenson
uin	211556
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Data on adult obesity and excess weight (overweight and obese) for Pendle district are available from the ‘Local Health Profiles’ using data from the ‘Active People Survey’ commissioned by Sport England. The data are only available for 2012 and are presented as a total figure for males and females. This data is not collected by parliamentary constituency. The following data are for the area of Pendle district.</p><p> </p><p> </p><p> </p><p>Excess weight defined as the proportion of the adult population who are overweight or obese for Pendle district in 2012 was 67.7% (England 63.8%).</p><p> </p><p> </p><p> </p><p>The proportion of the adult population in Pendle district classified as obese in 2012 was 25.3% (England 23.0%).</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:41:28 answering member 3918 label Biography information for Jane Ellison
tabling member	4044 label Biography information for Andrew Stephenson

100405

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Pendle
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many children in Pendle constituency were classified as (a) overweight and (b) obese in each year since 2006-07.
tabling member constituency	Pendle
tabling member printed	Andrew Stephenson
uin	211555
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Data on childhood obesity are not collected by parliamentary constituency. The following data are for the area of Pendle district. The National Childhood Measurement Programme (NCMP) data collection began in 2006-07 and only collects data on two age groups; reception year (4-5 years) and year 6 (10-11 years).</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td colspan="4"><p>Reception Year (4-5 years)</p></td><td colspan="4"><p>Year 6 (10-11 years)</p></td></tr><tr><td><p> </p></td><td colspan="2"><p>Prevalence of obesity</p></td><td colspan="2"><p>Prevalence of overweight (including obese)</p></td><td colspan="2"><p>Prevalence of obesity</p></td><td colspan="2"><p>Prevalence of overweight (including obese)</p></td></tr><tr><td><p> </p></td><td><p>Children</p></td><td><p>%</p></td><td><p>Children</p></td><td><p>%</p></td><td><p>Children</p></td><td><p>%</p></td><td><p>Children</p></td><td><p>%</p></td></tr><tr><td><p>2006-07</p></td><td><p>94</p></td><td><p>10.84</p></td><td><p>191</p></td><td><p>22.03</p></td><td><p>50</p></td><td><p>13.59</p></td><td><p>99</p></td><td><p>26.9</p></td></tr><tr><td><p>2007-08</p></td><td><p>89</p></td><td><p>10.06</p></td><td><p>193</p></td><td><p>21.81</p></td><td><p>152</p></td><td><p>18.36</p></td><td><p>251</p></td><td><p>30.31</p></td></tr><tr><td><p>2008-09</p></td><td><p>82</p></td><td><p>7.98</p></td><td><p>219</p></td><td><p>21.32</p></td><td><p>159</p></td><td><p>16.31</p></td><td><p>279</p></td><td><p>28.62</p></td></tr><tr><td><p>2009-10</p></td><td><p>102</p></td><td><p>9.51</p></td><td><p>253</p></td><td><p>23.58</p></td><td><p>175</p></td><td><p>17.82</p></td><td><p>307</p></td><td><p>31.26</p></td></tr><tr><td><p>2010-11</p></td><td><p>106</p></td><td><p>9.84</p></td><td><p>256</p></td><td><p>23.77</p></td><td><p>163</p></td><td><p>17.25</p></td><td><p>291</p></td><td><p>30.79</p></td></tr><tr><td><p>2011-12</p></td><td><p>115</p></td><td><p>10.48</p></td><td><p>271</p></td><td><p>24.7</p></td><td><p>192</p></td><td><p>19.12</p></td><td><p>352</p></td><td><p>35.06</p></td></tr><tr><td><p>2012-13</p></td><td><p>151</p></td><td><p>12.46</p></td><td><p>313</p></td><td><p>25.83</p></td><td><p>188</p></td><td><p>19.54</p></td><td><p>339</p></td><td><p>35.24</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><em>Source</em>: Health and Social Care Information Centre, National Childhood Measurement Programme.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:23:51 answering member 3918 label Biography information for Jane Ellison
tabling member	4044 label Biography information for Andrew Stephenson

100410

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the letter dated 7 March 2014 from the Minister for Public Health to the hon. Member for Kingston upon Hull North (reference POC4 845965) if he will place in the Library all documents in the possession of his Department relating to the advice received from an independent group of experts when the Skipton Fund was first established in 2003-04 in relation to the practicality of the State 1/Stage 2 Hepatitis C distinction.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211638
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>We will arrange for all of the documents relating to the advice received from the group of independent experts which provided advice on the medical trigger for Skipton Fund stage 2 payments in 2003-04, to be placed in the Library by 14 November 2014.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:17:54 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson